1: Are classified by the BNF as 'less suitable for prescribing', and includes anti-malarials (where a private prescription may be provided). Have a lack of data on effectiveness compared with standard therapy
7: Those that are deemed by national publications (e.g. by NHSE/ NHS Clinical Commissioners) of limited value, unless agreed by local agreement
